Your Mounjaro price guide · October 2026
SGLT2 and GLP-1 Combination: What UK Patients Should Know (October 2026)
Taking an SGLT2 inhibitor and a GLP-1 medicine together is a decision for your prescriber or diabetes team, not something to start, stop or adjust yourself. They are different classes of medicine. Mounjaro (tirzepatide) is not an SGLT2 inhibitor: it activates the GIP and GLP-1 receptors.1 Current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Why this question comes up
People with type 2 diabetes are often prescribed more than one medicine, so it is natural to ask how an SGLT2 inhibitor and a GLP-1 medicine relate.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
An SGLT2 inhibitor and a GLP-1 medicine are different classes; whether to combine them is your prescriber's call, based on your full history.
-
Mounjaro is not an SGLT2 inhibitor. Tirzepatide activates both GIP and GLP-1 receptors.
-
We do not supply SGLT2 inhibitors, so ask your GP, diabetes nurse or pharmacist about combining them.
-
Tell any prescriber about every medicine you take, including diabetes tablets, insulin and supplements.
-
Trial results quoted here are for tirzepatide alone with diet and exercise, never for a combination.
In this guide
01 · The core answer
Can you be on both an SGLT2 inhibitor and a GLP-1 medicine?
It can be possible, but whether it is right for you is a clinical decision made by a prescriber who knows your diabetes, kidney function, current medicines and history. Your own situation is what counts.
The two classes are not interchangeable. A GLP-1 medicine works on gut-hormone receptors. An SGLT2 inhibitor belongs to a different group of medicines, with its own patient leaflet, its own side effects and its own monitoring. Reading both leaflets side by side is a sensible first step before any appointment.
If you already take an SGLT2 inhibitor such as dapagliflozin and are thinking about adding a weekly injection, do not change anything on your own. Raise it with the clinician who prescribed the tablet, or with the prescriber reviewing your consultation. Our team reviews your full medicines list as part of the consultation.
02 · At a glance
How the medicines compare
| Medicine | Type | How it is given | What is known |
|---|---|---|---|
| Mounjaro (tirzepatide) | Dual GIP and GLP-1 receptor activator | Once-weekly pen in six strengths, 2.5mg to 15mg | Licensed in the UK for weight management in adults and for type 2 diabetes1 |
| Wegovy (semaglutide) | GLP-1 receptor agonist | Once-weekly pen: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg | 2.4mg is the licensed maintenance dose for weight management |
| Liraglutide (Saxenda and similar) | GLP-1 receptor agonist | Daily injection, 6mg/ml | Daily, unlike the weekly pens |
| SGLT2 inhibitors (for example dapagliflozin) | A different class from GLP-1 medicines | See the product's own patient leaflet | Not supplied by us; ask your GP, diabetes nurse or the leaflet |
Mounjaro is a GLP-1 and GIP medicine. It is not an SGLT2 inhibitor, and it does not replace one. If you are curious how the two groups compare in general terms, our guide to a GLP-1 agonist versus an SGLT2 inhibitor sets out the differences, and the page on SGLT2 and Mounjaro covers the tirzepatide side.
03 · Your next step
What to do next
If you are a private patient wanting treatment for weight management, start with a free online consultation. Be completely open about any diabetes medicines, including SGLT2 inhibitors, because they affect what the prescriber considers safe. Our weight loss clinic explains the options, and the Mounjaro pen page has more about the treatment.
If you are managing diabetes through the NHS, your diabetes team stays in charge of your diabetes medicines. Do not stop an existing tablet because you have read something online, and do not start a new injection without telling them.
Related guide: Dpp4 and glp 1 combination.
04 · How Mounjaro works
How Mounjaro works, and why it is not an SGLT2 inhibitor
Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.1 Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.
That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic). It is also why the question "Is Mounjaro an SGLT2 inhibitor?" has a clear answer: no. Tirzepatide works through gut-hormone receptors. An SGLT2 inhibitor is a separate class with its own leaflet.
Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. It is taken once a week. Keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away.13
Because the two classes act differently, reading about one does not tell you how the other behaves. Keep that in mind when you see pages that blur them together. If you want the wider picture of how GLP-1 treatments relate to other diabetes medicines, our page on GLP-1 and SGLT2 medicines is a good companion read.
05 · What trials show
What the weight-loss evidence does and does not cover
The headline tirzepatide trial is SURMOUNT-1, and it tested tirzepatide alone alongside diet and exercise. It did not test tirzepatide combined with an SGLT2 inhibitor, so it cannot tell you what a combination would do.
In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.
At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2
For a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. Trial averages do not predict your own result.
06 · Dapagliflozin questions
Dapagliflozin questions
Can dapagliflozin be used with a GLP-1 medicine? That is a prescriber's decision. The dapagliflozin patient leaflet lists medicines to tell your clinician about, and your GP or diabetes nurse can check your particular combination. Our reviewing prescriber will also ask about it during a consultation.
What should I avoid while taking dapagliflozin? The patient information leaflet that came with your supply is the authoritative list. Read the section on what to tell your doctor before taking it, and the section on possible side effects.
Does it reduce appetite or cause rapid weight loss? If you notice rapid or unexpected weight change on any medicine, speak to your prescriber or pharmacist.
How long can you stay on it? Duration is set by the clinician who prescribes it and reviews you. Never stop a long-term diabetes medicine on your own.
Ozempic or dapagliflozin? These are different classes with different jobs, and the choice belongs to you and your diabetes team. If you suspect a side effect from any medicine, you can report it through the Yellow Card scheme.19
07 · Licence and NHS access
Licence, NHS access and who Mounjaro is for
In the UK, Mounjaro is licensed for weight management in adults and for type 2 diabetes.1 NICE has separate guidance for each use: one covering overweight and obesity, and one covering type 2 diabetes.48
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
If you have type 2 diabetes and are already on NHS care, your diabetes team decides what is added to your regimen. Private treatment through us is an alternative route, not a replacement for that relationship, and you should keep your team informed.
Other combinations raise similar questions. Our page on insulin with GLP-1 medicines explains the points that apply there.
08 · Preparing for a consultation
How to prepare when you take other medicines
If you take an SGLT2 inhibitor or any other diabetes medicine, a little preparation makes the consultation faster and safer. A prescriber can only judge suitability on what you tell them.
- Write down every medicine by name, including tablets, injections, insulin, creams and supplements.
- Note who prescribes each one and when it was last reviewed.
- Have your most recent diabetes review details to hand, if you have them.
- List any conditions, past reactions or allergies.
- Say whether you are pregnant, planning a pregnancy or breastfeeding. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
- Bring your questions about combining medicines, in writing, so you do not forget them.
Our consultation is free, with no obligation. It is reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
Repeat orders re-check suitability, so if your medicines change, for example when a new tablet is started, tell us before you reorder. We do not auto-ship.
09 · Safety and reporting
Safety, side effects and reporting
Any new symptom after starting or combining medicines deserves a conversation with your prescriber. Do not wait to see whether it passes if it worries you.
You can report suspected side effects from any medicine, including Mounjaro and SGLT2 inhibitors, through the MHRA Yellow Card scheme.19 Reports help regulators spot patterns, and anyone can make one.
Buy only from a registered pharmacy. Anyone offering to supply a prescription medicine without a consultation or prescription is a warning sign, and counterfeit medicine alerts are published by the MHRA.7 You can check our registration, GPhC 9012878, on the GPhC register.12
Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.
10 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
11 · How ordering works
How ordering works with us
If you decide a Mounjaro pen is worth discussing, the process is straightforward and the consultation comes first.
- Free online consultation. A short health questionnaire, with no charge and no obligation.
- Prescriber review. A GPhC-registered prescriber reviews your answers. If treatment is unsuitable, the order is refunded automatically.
- Dispensing and delivery. Our registered pharmacy dispenses, with same-day dispatch when ordered by 3pm, then free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.
Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. Needles, a sharps bin and injection guidance are included with every order, and ongoing monthly reviews are part of the service.
The free GLPTrackr companion app can help you keep a record of doses and symptoms, which is useful to share at reviews.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamCan you be on both SGLT2 and GLP-1?
Is Mounjaro a SGLT2i?
Can dapagliflozin be used with a GLP-1 medicine?
Which is better, Ozempic or dapagliflozin?
What to avoid while taking dapagliflozin?
Does dapagliflozin cause rapid weight loss or reduce appetite?
Can I get Mounjaro if I already take an SGLT2 inhibitor?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 9 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- NICE TA924 — Tirzepatide for treating type 2 diabetes
- GPhC — public register of pharmacies and pharmacy professionals
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


